Weekly News Recap #Phispers
Lilly to invest US$ 3 bn in China to boost supply of new obesity drug; Servier acquires Day One Biopharma for US$ 2.5 bn
In Phispers this week, Eli Lilly announced its plans to invest US$
3 billion in China over the next decade in order to build p...
Impressions : 2553
US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations
Public health suffered several setbacks over the last week. First,
the United States formally exited the World Health Organiza...
Impressions : 1994
Sanofi gets two bids valuing its consumer unit at US$ 17 bn; Pfizer pulls SCD drug from market
In news this week, Sanofi is considering the sale of its consumer
health unit and has received binding bids valuing the divisi...
Impressions : 1512
Astra’s cancer drugs impress at ASCO; Moderna’s mRESVIA becomes first mRNA RSV vaccine approved by FDA
This week saw the American Society of Clinical Oncology (ASCO) annual meeting in Chicago where cancer researchers presented det...
Impressions : 1231
BMS buys biopharma firm MyoKardia for US$ 13.1 billion; Concerns emerge over quality of acetazolamide
This week, Phispers has more updates on Covid-19 vaccines and therapies.
In the US, President Donald Trump contracted the vir...
Impressions : 88815
Trump says Pfizer’s vaccine likely to be first Covid vaccine available; Dr Reddy’s settles blockbuster patent suit with BMS
This week, Phispers has lots of updates on experimental vaccines for Covid-19.
US President Donald Trump has said Pfizer coul...
Impressions : 51700
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.